Valuation: Shandong Linuo Pharmaceutical Packaging Co., Ltd.

Market Cap 11.82B 1.74B 1.52B 1.4B 1.3B 2.47B 165B 2.51B 16.83B 6.54B 81.5B 6.53B 6.39B 282B P/E 2026 *
117x
P/E 2027 * 89.4x
Enterprise Value 11.82B 1.74B 1.52B 1.4B 1.3B 2.47B 165B 2.51B 16.83B 6.54B 81.5B 6.53B 6.39B 282B EV / Sales 2026 *
10.8x
EV / Sales 2027 * 9.55x
Free-Float
64.5%
Yield 2026 *
-
Yield 2027 * -
06-03 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2025, Payable on 9 June 2026 CI
04-22 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-21 Shandong Linuo Pharmaceutical Packaging Co., Ltd. announces Annual dividend, payable on June 09, 2026 CI
04-20 Shandong Linuo Pharmaceutical Packaging Co., Ltd. announced that it expects to receive CNY 300 million in funding CI
04-06 Nuode Fund Management Co., Ltd., Caitong Fund Management Co., Ltd., Jinxiu Zhonghe Investment Management Co., Ltd. and Allianz Asset Management Co., Ltd acquired 2.99% stake in Shandong Linuo Pharmaceutical Packaging Co., Ltd. from Linuo Investment Holding Group Co., Ltd. for approximately CNY 130 million. CI
03-31 Shandong Linuo Pharmaceutical Packaging's controlling shareholder plans to sell 3.0% stake RE
12-15 Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025. CI
12-14 Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback announced on February 7, 2025, has closed with 4,557,700 shares, representing 1.99% for CNY 81.11 million. CI
11-03 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Approves Board Elections CI
27/10/25 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
09/10/25 Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025. CI
28/09/25 Shandong Linuo Pharmaceutical Packaging Co., Ltd. completed the acquisition of 30% stake in Suzhou Chuangyang New Materials Technology Co., Ltd. from Shanghai Miaoxiang Enterprise Management Consulting Co., Ltd., Taicang Chuangyang Qiyun Enterprise Management Partnership Enterprise (Limited Partnership), Shanghai Shizhi Enterprise Management Co., Ltd. and Shanghai Jiuban Intelligent Technology Co., Ltd. CI
09/09/25 Shandong Linuo Pharmaceutical Packaging's shareholder to unload shares RE
1 day-3.13%
1 week-27.87%
Current month-31.88%
1 month-16.68%
3 months+106.29%
6 months+157.17%
Current year+158.92%
1 week 44.6
Extreme 44.6
66.47
1 month 44.6
Extreme 44.6
76.3
Current year 15.07
Extreme 15.07
76.3
1 year 15.07
Extreme 15.07
76.3
3 years 10.78
Extreme 10.78
76.3
5 years 10.78
Extreme 10.78
76.3
10 years 10.78
Extreme 10.78
76.3
Manager TitleAgeSince
Chief Executive Officer 46 14/04/2024
Director of Finance/CFO 45 28/11/2022
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 68 30/10/2025
Director/Board Member 77 14/04/2024
Director/Board Member 60 14/04/2024
Change 5-day change 1-year change 3-year change Capi.($)
-3.13%-27.87%+121.54%+165.56% 1.8B
+1.80%+7.63%-1.23%+22.26% 3.56B
+1.66%+7.32%-28.35%-39.64% 2.68B
-3.42%-1.31%-17.69%-34.22% 1.83B
-1.44%+2.08%-37.47%-54.11% 1.54B
-0.41%+2.09%-14.47%-50.81% 742M
-0.99%-0.11%+47.84%+38.60% 608M
-0.58%-3.10%+71.10%+51.03% 598M
-2.55%+1.78%-42.05%-55.16% 463M
-0.18%-0.18%+114.72%+117.34% 381M
Average -0.90%-0.51%+21.39%+16.08% 1.42B
Weighted average by Cap. -0.40%-0.18%+9.38%+11.30%

Financials

2026 *2027 *
Net sales 1.09B 160M 140M 129M 120M 228M 15.22B 231M 1.55B 603M 7.51B 602M 589M 25.97B 1.24B 182M 159M 147M 136M 259M 17.29B 263M 1.76B 685M 8.53B 684M 669M 29.5B
Net income 103M 15.16M 13.26M 12.22M 11.33M 21.51M 1.44B 21.86M 147M 57.01M 710M 56.91M 55.68M 2.45B 137M 20.16M 17.64M 16.26M 15.07M 28.61M 1.91B 29.07M 195M 75.82M 944M 75.69M 74.05M 3.26B
Net Debt - -
Logo Shandong Linuo Pharmaceutical Packaging Co., Ltd.
Shandong Linuo Pharmaceutical Packaging Co Ltd, formerly Shandong Linuo Technical Glass Co Ltd, is a China-based company specialized in the research, development, production and sales of borosilicate special glass. The Company's main products include medium borosilicate pharmaceutical glass and high borosilicate heat-resistant glass series products. Pharmaceutical glass products include low borosilicate pharmaceutical glass series and medium borosilicate pharmaceutical glass series, which are mainly used in medical packaging fields such as blood products, biopharmaceuticals, new drugs and special drugs, vaccines, etc. High borosilicate heat-resistant glass products include heat-resistant glassware, glass trays for microwave ovens, glass lenses, electric light source glass shells and electric light source glass tubes, and others, which are mainly used in residential life fields including dining utensils, kitchen utensils, lighting fixtures, and others.
Employees
1,403
Date Price Change Volume
06/07/26 CN¥45.57 -3.13% 15,016,844
06/07/26 CN¥47.04 -8.75% 22,553,950
03/07/26 CN¥51.55 -10.25% 29,221,149
02/07/26 CN¥57.44 -9.40% 24,780,815
01/07/26 CN¥63.40 -5.23% 17,773,273

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 301188 Stock